Help us keep you updated.

Please let us know more about you.

Help us keep you updated.

Please let us know more about you.

Indiana

Cumulative Cost to Jan 31, 2022: $8.7B

% of Population with Long Covid: 7.3%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 481,100

# of Individuals with Disabling Long Covid: 160,000

Illinois

Cumulative Cost to Jan 31, 2022: $16B

% of Population with Long Covid: 10%

% of Population with Disabling Long Covid: 4%

# of Individuals with Long Covid: 860,000

# of Individuals with Disabling Long Covid: 285,000

Idaho

Cumulative Cost to Jan 31, 2022: $2B

% of Population with Long Covid: 6.7%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 113,000

# of Individuals with Disabling Long Covid: 37,500

Hawaii

Cumulative Cost to Jan 31, 2022: $1.1B

% of Population with Long Covid: 4.4%

% of Population with Disabling Long Covid: 1.4%

# of Individuals with Long Covid: 62,000

# of Individuals with Disabling Long Covid: 20,500

Georgia

Cumulative Cost to Jan 31, 2022: $12.6B

% of Population with Long Covid: 6.8%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 702,000

# of Individuals with Disabling Long Covid: 233,000

Florida

Cumulative Cost to Jan 31, 2022: $30B

% of Population with Long Covid: 7.9%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 1,640,000

# of Individuals with Disabling Long Covid: 544,000

Delaware

Cumulative Cost to Jan 31, 2022: $1.3B

% of Population with Long Covid: 7.7%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 73,000

# of Individuals with Disabling Long Covid: 24,000

Connecticut

Cumulative Cost to Jan 31, 2022: $3.7B

% of Population with Long Covid: 5.7%

% of Population with Disabling Long Covid: 1.9%

# of Individuals with Long Covid: 205,000

# of Individuals with Disabling Long Covid: 68,000

Colorado

Cumulative Cost to Jan 31, 2022: $6.7B

% of Population with Long Covid: 6.7%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 370,00

# of Individuals with Disabling Long Covid: 123,000

California

Cumulative Cost to Jan 31, 2022: $43B

% of Population with Long Covid: 6.3%

% of Population with Disabling Long Covid: 2.1%

# of Individuals with Long Covid: 2,470,000

# of Individuals with Disabling Long Covid: 817,000

Arkansas

Cumulative Cost to Jan 31, 2022: $4.1B

% of Population with Long Covid: 7.7%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 230,000

# of Individuals with Disabling Long Covid: 76,500

Arizona

Cumulative Cost to Jan 31, 2022: $9.8B

% of Population with Long Covid: 8%

% of Population with Disabling Long Covid: 2.7%

# of Individuals with Long Covid: 554,000

# of Individuals with Disabling Long Covid: 184,000

Alaska

Cumulative Cost to Jan 31, 2022: $1B

% of Population with Long Covid: 8.4%

% of Population with Disabling Long Covid: 2.8%

# of Individuals with Long Covid: 62,000

# of Individuals with Disabling Long Covid: 21,000

Oregon

Cumulative Cost to Jan 31, 2022: $3.3B

% of Population with Long Covid: 4.6%

% of Population with Disabling Long Covid: 1.5%

# of Individuals with Long Covid: 187,000

# of Individuals with Disabling Long Covid: 62,000

Alabama

Cumulative Cost to Jan 31, 2022: $6.5B

% of Population with Long Covid: 7.5%

% of Population with Disabling Long Covid: 2.5%

# of Individuals with Long Covid: 363,000

# of Individuals with Disabling Long Covid: 121,000

Washington

Cumulative Cost to Jan 31, 2022: $6.7B

% of Population with Long Covid: 5.4%

% of Population with Disabling Long Covid: 1.8%

# of Individuals with Long Covid: 394,000

# of Individuals with Disabling Long Covid: 130,000

Wyoming

Cumulative Cost to Jan 31, 2022: $775M

% of Population with Long Covid: 7.5%

% of Population with Disabling Long Covid: 2.5%

# of Individuals with Long Covid: 43,500

# of Individuals with Disabling Long Covid: 14,500

Wisconsin

Cumulative Cost to Jan 31, 2022: $8.1B

% of Population with Long Covid: 7.8%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 450,000

# of Individuals with Disabling Long Covid: 150,000

West Virginia

Cumulative Cost to Jan 31, 2022: $2.3B

% of Population with Long Covid: 7.2%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 132,000

# of Individuals with Disabling Long Covid: 44,000

Virginia

Cumulative Cost to Jan 31, 2022: $8.2B

% of Population with Long Covid: 5.4%

% of Population with Disabling Long Covid: 1.8%

# of Individuals with Long Covid: 457,000

# of Individuals with Disabling Long Covid: 151,000

Vermont

Cumulative Cost to Jan 31, 2022: $500M

% of Population with Long Covid: 4.5%

% of Population with Disabling Long Covid: 1.5%

# of Individuals with Long Covid: 28,000

# of Individuals with Disabling Long Covid: 9,000

Utah

Cumulative Cost to Jan 31, 2022: $4.7B

% of Population with Long Covid: 10%

% of Population with Disabling Long Covid: 4%

# of Individuals with Long Covid: 262,000

# of Individuals with Disabling Long Covid: 87,000

Texas

Cumulative Cost to Jan 31, 2022: $33B

% of Population with Long Covid: 6.6%

% of Population with Disabling Long Covid: 2%

# of Individuals with Long Covid: 1,840,000

# of Individuals with Disabling Long Covid: 611,000

Tennessee

Cumulative Cost to Jan 31, 2022: $9.9B

% of Population with Long Covid: 8.3%

% of Population with Disabling Long Covid: 2.8%

# of Individuals with Long Covid: 555,000

# of Individuals with Disabling Long Covid: 184,000

South Dakota

Cumulative Cost to Jan 31, 2022: $1.2B

% of Population with Long Covid: 7.8%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 67,000

# of Individuals with Disabling Long Covid: 22,100

South Carolina

Cumulative Cost to Jan 31, 2022: $7.2B

% of Population with Long Covid: 8.3%

% of Population with Disabling Long Covid: 2.7%

# of Individuals with Long Covid: 410,000

# of Individuals with Disabling Long Covid: 136,000

Rhode Island

Cumulative Cost to Jan 31, 2022: $1.8B

% of Population with Long Covid: 9.5%

% of Population with Disabling Long Covid: 3.1%

# of Individuals with Long Covid: 100,000

# of Individuals with Disabling Long Covid: 33,000

Pennsylvania

Cumulative Cost to Jan 31, 2022: $14B

% of Population with Long Covid: 6.1%

% of Population with Disabling Long Covid: 2%

# of Individuals with Long Covid: 783,000

# of Individuals with Disabling Long Covid: 260,000

Oklahoma

Cumulative Cost to Jan 31, 2022: $5.1B

% of Population with Long Covid: 7.4%

% of Population with Disabling Long Covid: 2.5%

# of Individuals with Long Covid: 290,000

# of Individuals with Disabling Long Covid: 96,000

Ohio

Cumulative Cost to Jan 31, 2022: $14B

% of Population with Long Covid: 6.6%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 763,000

# of Individuals with Disabling Long Covid: 253,000

North Dakota

Cumulative Cost to Jan 31, 2022: $1.2B

% of Population with Long Covid: 8.8%

% of Population with Disabling Long Covid: 2.9%

# of Individuals with Long Covid: 66,500

# of Individuals with Disabling Long Covid: 22,000

North Carolina

Cumulative Cost to Jan 31, 2022: $12.6B

% of Population with Long Covid: 7.1%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 716,000

# of Individuals with Disabling Long Covid: 238,000

New York

Cumulative Cost to Jan 31, 2022: $17.5B

% of Population with Long Covid: 7.2%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 1,400,000

# of Individuals with Disabling Long Covid: 464,000

New Mexico

Cumulative Cost to Jan 31, 2022: $2.5B

% of Population with Long Covid: 6.8%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 142,000

# of Individuals with Disabling Long Covid: 47,000

New Jersey

Cumulative Cost to Jan 31, 2022: $11B

% of Population with Long Covid: 7%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 619,000

# of Individuals with Disabling Long Covid: 205,000

New Hampshire

Cumulative Cost to Jan 31, 2022: $1.5B

% of Population with Long Covid: 6.1%

% of Population with Disabling Long Covid: 2%

# of Individuals with Long Covid: 81,500

# of Individuals with Disabling Long Covid: 27,000

Nevada

Cumulative Cost to Jan 31, 2022: $3.5B

% of Population with Long Covid: 6.7%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 195,000

# of Individuals with Disabling Long Covid: 65,000

Nebraska

Cumulative Cost to Jan 31, 2022: $2.4B

% of Population with Long Covid: 6.9%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 131,000

# of Individuals with Disabling Long Covid: 43,500

Montana

Cumulative Cost to Jan 31, 2022: $1.3B

% of Population with Long Covid: 6.9%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 72,000

# of Individuals with Disabling Long Covid: 24,000

Missouri

Cumulative Cost to Jan 31, 2022: $7.1B

% of Population with Long Covid: 6.5%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 394,000

# of Individuals with Disabling Long Covid: 131,000

Mississippi

Cumulative Cost to Jan 31, 2022: $3.9B

% of Population with Long Covid: 7.2%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 216,000

# of Individuals with Disabling Long Covid: 72,000

Minnesota

Cumulative Cost to Jan 31, 2022: $7B

% of Population with Long Covid: 7.1%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 391,000

# of Individuals with Disabling Long Covid: 130,000

Michigan

Cumulative Cost to Jan 31, 2022: $12B

% of Population with Long Covid: 6.7%

% of Population with Disabling Long Covid: 2.2%

# of Individuals with Long Covid: 669,000

# of Individuals with Disabling Long Covid: 222,000

Massachusetts

Cumulative Cost to Jan 31, 2022: $8.6B

% of Population with Long Covid: 6.9%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 472,000

# of Individuals with Disabling Long Covid: 156,000

Maryland

Cumulative Cost to Jan 31, 2022: $5.2B

% of Population with Long Covid: 4.7%

% of Population with Disabling Long Covid: 1.6%

# of Individuals with Long Covid: 281,000

# of Individuals with Disabling Long Covid: 93,000

Maine

Cumulative Cost to Jan 31, 2022: $940M

% of Population with Long Covid: 3.9%

% of Population with Disabling Long Covid: 1.3%

# of Individuals with Long Covid: 52,000

# of Individuals with Disabling Long Covid: 17,000

Louisiana

Cumulative Cost to Jan 31, 2022: $5.9B

% of Population with Long Covid: 7.1%

% of Population with Disabling Long Covid: 2.4%

# of Individuals with Long Covid: 330,000

# of Individuals with Disabling Long Covid: 110,000

Kentucky

Cumulative Cost to Jan 31, 2022: $6.1B

% of Population with Long Covid: 7.8%

% of Population with Disabling Long Covid: 2.6%

# of Individuals with Long Covid: 344,000

# of Individuals with Disabling Long Covid: 114,000

Kansas

Cumulative Cost to Jan 31, 2022: $3.9B

% of Population with Long Covid: 7.4%

% of Population with Disabling Long Covid: 2.5%

# of Individuals with Long Covid: 216,000

# of Individuals with Disabling Long Covid: 72,000

Iowa

Cumulative Cost to Jan 31, 2022: $3.9B

% of Population with Long Covid: 6.8%

% of Population with Disabling Long Covid: 2.3%

# of Individuals with Long Covid: 214,000

# of Individuals with Disabling Long Covid: 71,000

Washington D.C.

Cumulative Cost to Jan 31, 2022: $700M

% of Population with Long Covid: 5.6%

% of Population with Disabling Long Covid: 1.9%

# of Individuals with Long Covid: 38,000

# of Individuals with Disabling Long Covid: 13,000

Help us keep you updated.​..

Please let us know more about you.